COMPANY OVERVIEW
Quris AI, headquartered in Tel Aviv, Israel, uniquely combines patient-on-chip biological systems with artificial intelligence to predict drug safety. Their platform integrates miniaturized human organ models with machine learning algorithms trained on clinical outcomes to achieve unprecedented predictive accuracy.
PLATFORM TECHNOLOGY
- Patient-on-Chip: iPSC-derived multi-organ systems
- BioAI Engine: ML models trained on clinical trial outcomes
- Genomic Diversity: Population-representative patient avatars
- Real-Time Sensing: Continuous biomarker monitoring
KEY APPLICATIONS
- Clinical trial failure prediction before human studies
- Population-specific toxicity risk assessment
- Drug rescue for failed clinical candidates
- Personalized medicine patient stratification